Joseph Edelman – RAPP history
- Issuer:
- RAPPORT THERAPEUTICS INC
- Quarters tracked:
- 8 (Q2 2024 → Q2 2026)
- Current shares:
- 773,342
- Current value:
- $32.23M
- Peak shares:
- 773,342 (Q2 2026)
- Overall change:
- +3%
| Quarter | Shares | Value | $/Share | Share Δ | Δ% |
|---|---|---|---|---|---|
| Q2 2026 | 773,342 | $32.23M | $41.67 | +99,419 | +15% |
| Q1 2026 | 673,923 | $21.09M | $31.29 | 0 | 0% |
| Q4 2025 | 673,923 | $20.45M | $30.34 | +270,000 | +67% |
| Q3 2025 | 403,923 | $12.00M | $29.70 | +403,923 | +100% |
| Q1 2025 | SOLD | — | — | -311,551 | -100% |
| Q4 2024 | 311,551 | $5.53M | $17.74 | -436,632 | -58% |
| Q3 2024 | 748,183 | $15.32M | $20.48 | 0 | 0% |
| Q2 2024 | 748,183 | $17.40M | $23.26 | — | NEW |